English Arabic Chinese (Simplified) Chinese (Traditional) Esperanto French German Hindi Latvian Luxembourgish Malayalam Maltese Norwegian Portuguese Russian Spanish Tajik

Musclepharm and Capstone enter manufacturing agreement

Print Share this

MUSCLEPHARM and CAPSTONE Nutrition team up for manufacturing processes

Press release: To go out immediately - MusclePharm Corporation, a scientifically driven, performance-lifestyle sports nutrition company, today announced it has entered into a strategic manufacturing agreement with an option to purchase Capstone Nutrition, one of the largest pure-play developers and manufacturers in the nutrition industry.

Under the terms of the agreement, MusclePharm will consolidate all of its domestic powder, capsule and tablet manufacturing into applicable Capstone facilities. 

"With more than two decades of experience developing and manufacturing high-quality products, Capstone is the ideal partner for MusclePharm as we look to become a diversified leader in the sports nutrition industry, with strength across innovation, manufacturing and brand development," said Brad Pyatt, founder and CEO of MusclePharm.

Upon exercise of the purchase option, the consolidated company is expected to have annual revenues of approximately $450 million.

Coinciding with this agreement, MusclePharm is also launching a contract manufacturing sales and business development team to complement the team at Capstone. The goal of this initiative would be to bring leading research, innovation and manufacturing capabilities to the broader industry. In addition to ensuring the seamless transition of MusclePharm products into Capstone's facilities, the team will focus on further enhancing the breadth of Capstone's current contract manufacturing capabilities.

Capstone operates two state-of-the-art facilities, focused on manufacturing capsules, tablets, powders and OTC products, along with a world-class flavor lab.

"Together, our companies reflect the very best in science, innovation, and high-quality manufacturing, and we welcome this mutually beneficial opportunity to align with MusclePharm at this exciting stage of growth for the company," said Greg Horn, CEO of Capstone. "Our other customers will benefit from the increase in capacity and buying power that this expansion brings to the Capstone system."